AURA Long Call Strategy
AURA (Aura Biosciences, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
AURA (Aura Biosciences, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $514.9M, a beta of 0.37 versus the broader market, a 52-week range of 4.345-9.535, average daily share volume of 437K, a public-listing history dating back to 2021, approximately 106 full-time employees. These structural characteristics shape how AURA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.37 indicates AURA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on AURA?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current AURA snapshot
As of May 15, 2026, spot at $7.72, ATM IV 174.80%, IV rank 32.52%, expected move 50.11%. The long call on AURA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on AURA specifically: AURA IV at 174.80% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 50.11% (roughly $3.87 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AURA expiries trade a higher absolute premium for lower per-day decay. Position sizing on AURA should anchor to the underlying notional of $7.72 per share and to the trader's directional view on AURA stock.
AURA long call setup
The AURA long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AURA near $7.72, the first option leg uses a $7.72 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AURA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AURA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $7.72 | N/A |
AURA long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
AURA long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on AURA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on AURA
Long calls on AURA express a bullish thesis with defined risk; traders use them ahead of AURA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
AURA thesis for this long call
The market-implied 1-standard-deviation range for AURA extends from approximately $3.85 on the downside to $11.59 on the upside. A AURA long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current AURA IV rank near 32.52% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on AURA should anchor more to the directional view and the expected-move geometry. As a Healthcare name, AURA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AURA-specific events.
AURA long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AURA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AURA alongside the broader basket even when AURA-specific fundamentals are unchanged. Long-premium structures like a long call on AURA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current AURA chain quotes before placing a trade.
Frequently asked questions
- What is a long call on AURA?
- A long call on AURA is the long call strategy applied to AURA (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With AURA stock trading near $7.72, the strikes shown on this page are snapped to the nearest listed AURA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AURA long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the AURA long call priced from the end-of-day chain at a 30-day expiry (ATM IV 174.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AURA long call?
- The breakeven for the AURA long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AURA market-implied 1-standard-deviation expected move is approximately 50.11%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on AURA?
- Long calls on AURA express a bullish thesis with defined risk; traders use them ahead of AURA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current AURA implied volatility affect this long call?
- AURA ATM IV is at 174.80% with IV rank near 32.52%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.